An Enhanced Hemostatic Factor VIII Variant for Hemophilia A Gene Therapy

被引：0
|
作者：
Sternberg, Anna R. [1 ,2 ]
Davidson, Robert J. [1 ]
Wilhelm, Amelia R. [1 ]
George, Lindsey A. [1 ,2 ]
机构：
[1] CHOP, Philadelphia, PA USA
[2] UPENN, Philadelphia, PA USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
697
引用
收藏
页码：328 / 329
页数：2
相关论文
共 50 条
  • [21] Ultrasound Combined with Microbubbles Mediated Factor VIII Plasmid Gene Therapy in Hemophilia a Mice
    Song, Shuxian
    Harrang, James
    Smith, Bryn
    Miao, Carol H.
    BLOOD, 2015, 126 (23)
  • [22] Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice
    Dwarki, V. J.
    Belloni, P.
    Nijjar, T.
    Smith, J.
    Proceedings of the National Academy of Sciences of the United States of America, 92 (04):
  • [23] Hemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectors
    Miao C.H.
    Thrombosis Journal, 14 (Suppl 1)
  • [24] Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A
    Ill, CR
    Yang, CQ
    Bidlingmaier, SM
    Gonzales, JN
    Burns, DS
    Bartholomew, RM
    Scuderi, P
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S23 - S30
  • [25] Platelet Factor VIII-Induced Megakaryocyte Apoptosis: Implications for Hemophilia A Gene Therapy
    Greene, Teshell K.
    Zhai, Li
    Razzo, Beatrice
    Vo, Karen
    Sabatino, Denise E.
    Camire, Rodney M.
    Arruda, Valder R.
    Poncz, Mortimer
    BLOOD, 2012, 120 (21)
  • [26] Factor VIII therapy for hemophilia A: current and future issues
    Aledort, Louis
    Ljung, Rolf
    Mann, Kenneth
    Pipe, Steven
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (03) : 373 - 385
  • [27] Efficacy of a PEGylated variant of recombinant factor VIII in mouse models of hemophilia A
    Hoellriegl, W.
    Schiviz, A.
    Eder, B.
    Verdino, D.
    Scheif-Linger, F.
    Schwarz, H.
    Muchitsch, E.
    HAEMOPHILIA, 2012, 18 : 37 - 37
  • [28] Hemostatic control of adenotonsillectomy with recombinant Fc-fused factor VIII in a boy with hemophilia A
    Doi, Masaaki
    Furuichi, Yasuko
    Yonei, Shinichi
    Nogami, Keiji
    PEDIATRICS INTERNATIONAL, 2020, 62 (09) : 1113 - 1115
  • [29] Superior in Vivo Hemostatic Properties of an Engineered Factor Va Variant for Hemophilia Mice
    Von Drygalski, Annette
    Cramer, Thomas J.
    Griffin, John H.
    Gale, Andrew J.
    Mosnier, Laurent O.
    BLOOD, 2012, 120 (21)
  • [30] Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII
    Yoshioka, A
    Nishio, K
    Shima, M
    HAEMOSTASIS, 1996, 26 : 139 - 142
12345